Some functions of this side are available with javascript only!
Norwegian Cancer Consortium - NCC
Explore the Research Trends
Explore the Research Network
This is a list of the 20 publications most recently added to the Research Profiles database. This shows the publication activity that is ongoing at the institution.The source of publications for this application is Scopus.
1.
Matthias Kolberg; Maren Høland; Trude H. Agesen; Helge R. Brekke; Knut Liestøl; Kirsten S. Hall; Fredrik Mertens; Piero Picci; Sigbjørn Smeland; Ragnhild A. Lothe
Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
2.
R. Luksch; A. Tienghi; K. Sundby Hall; F. Fagioli; P. Picci; E. Barbieri; L. Gandola; M. Eriksson; P. Ruggieri; P. Daolio; et al.
Primary metastatic Ewing's family tumors: Results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation
3.
Siv K. Bøhn; Kjell M. Russnes; Amrit K. Sakhi; Magne Thoresen; Marit Holden; JanØ Moskaug; Mari C. Myhrstad; Ole K. Olstad; Sigbjørn Smeland; Rune Blomhoff
Stress associated gene expression in blood cells is related to outcome in radiotherapy treated head and neck cancer patients
4.
Andreas Stensvold; Alv A. Dahl; Bjøn Brennhovd; Milada Cvancarova; Sophie D. Fosså; Wolfgang Lilleby; Karol Axcrona; Sigbjøn Smeland
Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones
5.
B. Bjerkehagen; M.C. Smstuen; K.S. Hall; S. Skjeldal; S. Smeland; S.D. Foss
Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival
6.
Tale Norbye Wien; Eva Pike; Torbjørn Wisløff; Annetine Staff; Sigbjørn Smeland; Marianne Klemp
Cancer risk with folic acid supplements: A systematic review and meta-analysis
7.
Geir O. Hjortland; Leonardo A. Meza-Zepeda; Klaus Beiske; Anne H. Ree; Siri Tveito; Hanne Hoifodt; Per J. Bohler; Knut H. Hole; Ola Myklebost; Oystein Fodstad; et al.
Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma
8.
Andreas Stensvold; Alv A. Dahl; Sophie D. Fosså; Karol Axcrona; Wolfgang Lilleby; Bjørn Brennhovd; Sigbjørn Smeland
Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center
9.
Sigbjørn Smeland; Øyvind S. Bruland; Lars Hjorth; Otte Brosjö; Bodil Bjerkehagen; Gustaf Österlundh; Åke Jakobson; Kirsten Sundby Hall; Odd R. Monge; Olle Björk; et al.
Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 Patients with a minimum follow-up of 4 years
10.
S. Ferrari; K. Sundby Hall; R. Luksch; A. Tienghi; T. Wiebe; F. Fagioli; T.A. Alvegard; A. Brach del Prever; A. Tamburini; M. Alberghini; et al.
Nonmetastatic Ewing family tumors: High-dose chemotherapy with stem cell rescue in poor responder patients. results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
11.
Amrit Kaur Sakhi; Siv Kjølsrud Bøhn; Sigbjørn Smeland; Magne Thoresen; Guro Berge Smedshaug; Johan Tausjø; Arne Svilaas; Anette Karlsen; Kjell Magne Russnes; Tone Svilaas; et al.
Postradiotherapy plasma lutein, α-carotene, and β-carotene are positively associated with survival in patients with head and neck squamous cell carcinoma
12.
Helge R. Brekke; Franclim R. Ribeiro; Matthias Kolberg; Trude H. Ågesen; Guro E. Lind; Mette Eknæs; Kirsten S. Hall; Bodil Bjerkehagen; Eva Van Den Berg; Manuel R. Teixeira; et al.
Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group
13.
Jeremy Whelan; Daniel Patterson; Martha Perisoglou; Stefan Bielack; Neyssa Marina; Sigbjorn Smeland; Mark Bernstein
The role of interferons in the treatment of osteosarcoma
14.
Christoph R. Müller; Heidi M. Namløs; Johan Bjerner; Ingrid H.G. Østensen; Gunnar Saeter; Sigbjørn Smeland; Øyvind S. Bruland; Ola Myklebost
Characterization of treatment response to recombinant interferon-α2b in osteosarcoma xenografts
15.
Christoph R. Müller; Heidi M. Namløs; Johan Bjerner; Ingrid H.G. Østensen; Gunnar Sæter; Sigbjørn Smeland; Øyvind S. Bruland; Ola Myklebost
16.
Amrit K. Sakhi; Kjell M. Russnes; Magne Thoresen; Nasser E. Bastani; Anette Karlsen; Sigbjørn Smeland; Rune Blomhoff
Pre-radiotherapy plasma carotenoids and markers of oxidative stress are associated with survival in head and neck squamous cell carcinoma patients: A prospective study
17.
Vidar Jetne; Stein Kvaløy; Sigbjørn Smeland; Tom Børge Johannesen; Kjell Magne Tveit
Bruk av stråleterapi i Helse Sør-Øst
18.
Helge R. Brekke; Matthias Kolberg; Rolf I. Skotheim; Kirsten S. Hall; Bodil Bjerkehagen; Björn Risberg; Henryk A. Domanski; Nils Mandahl; Knut Liestøl; Sigbjørn Smeland; et al.
Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
19.
Sigbjørn Smeland; Øyvind S. Bruland; Lars Hjorth; Otte Brosjö; Bodil Bjerkehagen; Gustaf Österlundh; Åke Jakobson; Kirsten Sundby Hall; Odd R. Monge; et al.
Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol
20.
Sigbjørn Smeland; Thomas Wiebe; Odd R. Monge; Otte Brosjö; Tom Böhling; Lars Hjorth; Kirsten Sundby Hall; Åke Jakobson; Thor A. Alvegaard
Treatment of localized Ewing sarcoma family of tumors the Scandinavian Sarcoma Group experience